Prostate Cancer Scientific Abstracts - R Dahiya
Welcome to the Prostate Cancer Guide scientific abstracts, author section R Dahiya.
This section is recommended for people who have a scientific interest in prostate cancer. It is recommended that people without prior knowledge of prostate cancer visit the more general areas of the site (Prostate Cancer Guide).
Selected R Dahiya prostate cancer abstracts
Journal: International Journal of cancer
Pubmed ID: 9311591
Authors: Dahiya R, Lee C, McCarville J, Hu W, Kaur G, Deng G.Title: High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma.
In order to investigate the genomic instability associated with prostate cancer,
36 microsatellite marker loci on chromosomes 1p, 3p, 5q, 8p, 8q, 9p, 11q and 13q
were analyzed using microdissected samples from prostate cancer and adjoining
microscopically normal tissues from the same slide. DNA was extracted from the
normal and tumor cells of 40 microdissected prostate-cancer samples, amplified
by PCR, and analyzed for microsatellite instability (MSI) using 36 different
polymorphic DNA markers. In the present study, we have utilized a highly refined
technique of PCR product separation on a sequencing gel, developed in our
laboratory, which clearly shows high-quality results for the microsatellite
instability in prostate cancer. The results of this study suggest that 45% (18
out of 40) showed genomic instability at a minimum of 1 locus; 4 cases each
showed MSI at one and 2 loci, 4 cases had MSI at 3 loci, 3 cases showed MSI at 5
loci, while one case each showed MSI at 7, 8 and 15 loci. There was no
significant correlation between the MSI and stage or grade of the tumors. This
extensive study on genomic instability in prostate cancer found the occurrence
of MSI to be very high, which suggests a role of MSI in the pathophysiology of
prostate cancer.
Contact: Department of Urology, University of California San Francisco and Veterans
Affairs Medical Center, 94121, USA.
Urologylab@aol.com
Journal: International Journal of cancer
Pubmed ID: 9219834
Authors: Dahiya R, McCarville J, Lee C, Hu W, Kaur G, Carroll P, Deng G.Title: Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer.
Loss of heterozygosity (LOH) on chromosome 11 is frequently altered in various
epithelial cancers. The present study was designed to investigate LOH on
chromosome 11 in microdissected samples of normal prostatic epithelium and
invasive carcinoma from the same patients. For this purpose, DNA was extracted
from the microdissected normal and tumor cells of 38 prostate cancers, amplified
by polymerase chain reaction PCR and analyzed for LOH on chromosome 11 using 9
different polymorphic DNA markers (D11S1307, D11S989, D11S1313, D11S898,
D11S940, D11S1818, D11S924, D11S1336 and D11S912). LOH on chromosome 11 was
identified in 30 of 38 cases (78%) with at least one marker. Four distinct
regions of loss detected were: 1) at 11p15, at loci between D11S1307 and
D11S989; 2) at 11p12, on locus D11S131 (11p12); 3) at 11q22, on loci D11S898,
D11S940 and D11S1818; and 4) at 11q23-24, on loci between D11S1336 and D11S912.
We found 25% of the tumors with LOH at 11p15; 39% had LOH at 11p12; 66% had LOH
at 11q22; and 47% had LOH at 11q23-24. These deletions at 11p15, 11p12, 11q22
and 11q23-24 loci were not related to the stage or grade of the tumor.